Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer
Open Access
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (11) , 1551-1559
- https://doi.org/10.1016/j.ejca.2005.01.027
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerAnnals of Oncology, 2005
- Quality of Life Among Disease-Free Survivors of Rectal CancerJournal of Clinical Oncology, 2004
- Health-Related Quality of Life in Female Long-Term Colorectal Cancer SurvivorsThe Oncologist, 2003
- Quality of life in long term survivors of colorectal cancerAmerican Journal of Gastroenterology, 2002
- Quality of Life in Breast and Colon Cancer Long-term Survivors: An Assessment with the Eortc Qlq-c30 and Sf-36 QuestionnairesTumori Journal, 2002
- Quality of life in survivors of colorectal carcinomaCancer, 2000
- Quality adjusted survival analysis with repeated quality of life measuresStatistics in Medicine, 1998
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality adjusted survival analysisStatistics in Medicine, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958